Karin Dahllöf elected to board of Histolab Products AB
Karin Dahllöf has been appointed to the Board of Directors of Histolab Products AB as of 1 October 2021. Dahllöf has a solid, diverse and international background that includes a number of commercial roles and leading positions in companies in the diagnostics and healthcare sectors. Since 2018, she has been CEO of Monivent AB, and she is also a board member of HemCheck Sweden AB and Boule Diagnostics AB.
“I welcome Karin Dahllöf to the board. She will make a valuable contribution to the strategic management and development of Histolab”, says Alexander Bargum, Chairman of the Board of Histolab Products AB and Group CEO of its parent company Algol.
“I am really looking forward to taking a seat on Histolab’s board, and I believe that my long experience and knowledge in medtech will benefit the company,” says Karin Dahllöf.
Alexander Bargum, Group CEO, Algol, Chairman of the Board, Histolab Products AB, tel. tel. +358 40 732 3232.
Algol in brief
Algol is a Finnish multi-branch company specialising in international trade. We have been operating responsibly with an international network of partners for more than 127 years. Our solutions improve the quality of industrial production and ensure smooth operations. In the healthcare sector Algol’s solutions promote the conditions for healthy living. The Algol Group had net sales of 151 million euro in 2020. We employ almost 500 professionals in ten countries.
Histolab Products in brief
Histolab Products AB is one of the leading suppliers of solutions for cell diagnostics research laboratories and clinical laboratories in the Nordics. The company supplies equipment and chemicals primarily to pathology and immunohistology laboratories. www.histolab.se/en.